Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole (2005)
Fonte: International Journal of Pharmaceutics. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, CÁPSULAS, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, PLASMA
ABNT
PORTA, Valentina e CHANG, K. H. e STORPIRTIS, Silvia. Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole. International Journal of Pharmaceutics, v. 288, n. 1, p. 81-86, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2004.09.013. Acesso em: 04 dez. 2025.APA
Porta, V., Chang, K. H., & Storpirtis, S. (2005). Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole. International Journal of Pharmaceutics, 288( 1), 81-86. doi:10.1016/j.ijpharm.2004.09.013NLM
Porta V, Chang KH, Storpirtis S. Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole [Internet]. International Journal of Pharmaceutics. 2005 ; 288( 1): 81-86.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1016/j.ijpharm.2004.09.013Vancouver
Porta V, Chang KH, Storpirtis S. Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole [Internet]. International Journal of Pharmaceutics. 2005 ; 288( 1): 81-86.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1016/j.ijpharm.2004.09.013
